Hydrogel-based drug delivery systems for enhanced tumor therapy
RSC Advances · 2026 · 16 (8) · 7430-7446
DOI: 10.1039/d5ra08269b ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift RSC Advances, 2026. Verfasst von Shijia Tian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Cell Engineering of Guizhou Province, Affiliated Hospital of Zunyi Medical University Zunyi 563000 China l_yfei@163.com yanfei_liu@…. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
This review highlights hydrogel-based platforms for spatiotemporally controlled, localized cancer therapy, overcoming drug resistance and modulating the tumor microenvironment to enhance efficacy and reduce toxicity for multiple treatment modalities.
Autor:innen und Institutionen
- Key Laboratory of Cell Engineering of Guizhou Province, Affiliated Hospital of Zunyi Medical University Zunyi 563000 China l_yfei@163.com yanfei_liu@zmu.edu.cn.
- Guizhou Biomanufacturing Laboratory, Affiliated Hospital of Zunyi Medical University Zunyi 563000 China.
- Department of Endocrinology, The Second Affiliated Hospital of Zunyi Medical University Zunyi 563006 China.
ORCID-Profile: Yanfei Liu
Zitieren
APA
Tian, S., Yang, S., & Liu, Y. (2026). Hydrogel-based drug delivery systems for enhanced tumor therapy. RSC Advances, 16(8), 7430-7446. https://doi.org/10.1039/d5ra08269b
Vancouver
Tian S, Yang S, Liu Y. Hydrogel-based drug delivery systems for enhanced tumor therapy. RSC Advances. 2026;16(8):7430-7446. doi:10.1039/d5ra08269b
BibTeX
@article{Tian2026,
author = {Tian, Shijia and Yang, Shuxiang and Liu, Yanfei},
title = {Hydrogel-based drug delivery systems for enhanced tumor therapy},
journal = {RSC Advances},
year = {2026},
volume = {16},
number = {8},
pages = {7430--7446},
doi = {10.1039/d5ra08269b}
}
EUVIMED